Your browser doesn't support javascript.
loading
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations.
Patel, Shyam A; Bello, Elisa; Wilks, Andrew; Gerber, Jonathan M; Sadagopan, Narayanan; Cerny, Jan.
Afiliação
  • Patel SA; Dept. of Medicine - Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA; Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, MA, USA.
  • Bello E; UMass Chan Medical School, Worcester, MA, USA.
  • Wilks A; Dept. of Medicine - Division of Hematology and Medical Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.
  • Gerber JM; Dept. of Medicine - Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA; Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, MA, USA.
  • Sadagopan N; MedStar Health - Georgetown/Washington Hospital Center Hematology and Medical Oncology, Washington, DC, USA.
  • Cerny J; Dept. of Medicine - Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA; Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, MA, USA. Electronic address: jan.cerny@umassmemorial.org.
Leuk Res ; 134: 107388, 2023 11.
Article em En | MEDLINE | ID: mdl-37729719

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Anticorpos Biespecíficos / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Anticorpos Biespecíficos / Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article